chr5-128083995-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001046.3(SLC12A2):c.41G>T(p.Gly14Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000264 in 1,249,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001046.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A2 | NM_001046.3 | c.41G>T | p.Gly14Val | missense_variant | 1/27 | ENST00000262461.7 | NP_001037.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A2 | ENST00000262461.7 | c.41G>T | p.Gly14Val | missense_variant | 1/27 | 1 | NM_001046.3 | ENSP00000262461 | P4 | |
SLC12A2 | ENST00000343225.4 | c.41G>T | p.Gly14Val | missense_variant | 1/26 | 1 | ENSP00000340878 | A2 | ||
SLC12A2 | ENST00000509205.5 | c.41G>T | p.Gly14Val | missense_variant, NMD_transcript_variant | 1/27 | 1 | ENSP00000427109 | |||
SLC12A2 | ENST00000628403.2 | c.41G>T | p.Gly14Val | missense_variant | 1/26 | 5 | ENSP00000486323 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 151704Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000820 AC: 9AN: 1097540Hom.: 0 Cov.: 30 AF XY: 0.00000955 AC XY: 5AN XY: 523820
GnomAD4 genome AF: 0.000158 AC: 24AN: 151704Hom.: 0 Cov.: 32 AF XY: 0.000189 AC XY: 14AN XY: 74098
ClinVar
Submissions by phenotype
Kilquist syndrome;C5436768:Hearing loss, autosomal dominant 78;C5436771:Delpire-McNeill syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 11, 2022 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.41G>T (p.G14V) alteration is located in exon 1 (coding exon 1) of the SLC12A2 gene. This alteration results from a G to T substitution at nucleotide position 41, causing the glycine (G) at amino acid position 14 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 14 of the SLC12A2 protein (p.Gly14Val). This variant is present in population databases (no rsID available, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with SLC12A2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1365125). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC12A2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at